按疾病诊断相关分组（DRGs）支付方式改革下基于药学版临床路径的药品费用控制策略研究

71804025
2018
G0405.健康管理与政策
李娜
青年科学基金项目
副教授
福建医科大学
21万元
循证药学;药品费用;药物经济学;疾病相关分组
2019-01-01到2021-12-31
  • 中英文摘要
  • 结题摘要
  • 结题报告
  • 项目成果
  • 项目参与人
查看更多信息请先登录或注册
查看更多信息请先登录或注册
查看更多信息请先登录或注册
重置
序号 标题 类型 作者
1 Cost-effectiveness analysis of screening for primary aldosteronism in China 期刊论文 Li Na;Huang Jingze;Zheng Bin;Cai Hongfu;Liu Maobai;Liu Libin
2 Cost-effectiveness of second-line nivolumab for platinum-treated advanced non-small-cell lung cancer. 期刊论文 Zhang Longfeng;Zeng Xiaofang;Cai Hongfu;Li Na;Liu Maobai;Qiu Lingling;Zheng Bin
3 Cost-Effectiveness Analysis of Olaparib Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancreatic Cancer 期刊论文 Li Na;Zheng Huanrui;Huang Yanlei;Zheng Bin;Cai Hongfu;Liu Maobai
4 Cost-effectiveness of antiosteoporosis strategies for postmenopausal women with osteoporosis in China 期刊论文 Li Na;Zheng Bin;Liu Maobai;Zhou Haimei;Zhao Lingfen;Cai Hongfu;Huang Jingze
5 2019年度中国药学会“施维雅青年医院药学奖” 奖励 李娜
6 Lenvatinib versus sorafenib for unresectable hepatocellular carcinoma: a cost-effectiveness analysis 期刊论文 Cai Hongfu;Zhang Longfeng;Li Na;Zheng Bin;Liu Maobai
7 Cost-Effectiveness Analysis Of Pembrolizumab In The Treatment Of Advanced Recurrent Metastatic Head And Neck Squamous Cell Carcinoma In China And The United States 期刊论文 Liu Maobai;Han Sijie;Zheng Bin;Cai Hongfu;Yang Jing;Zhuang Qian;Li Na
8 基于循证证据的我院出院带药处方前置审核系统的运行实践 期刊论文 魏娜;吴朝阳;陈伦灼;郑斌;李娜;吴小萍;王燕南;刘茂柏
9 生长抑素及其类似物联合质子泵抑制剂应用于急性非静脉曲张性上消化道出血的循证分析 期刊论文 魏娜;郑智源;郑斌;林荣芳;李娜;刘茂柏
10 Cost-effectiveness analysis on binary/triple therapy on the basis of ixazomib or bortezomib for refractory or relapsed multiple myeloma 期刊论文 Cai Hongfu;Zhang Longfeng;Li Na;Zheng Bin;Liu Maobai
11 2019年度中华医学会临床药学分会“优秀临床药师” 奖励 李娜
12 达可替尼对比吉非替尼一线治疗EGFR突变晚期或转移性非小细胞肺癌的成本效果分析 期刊论文 黄仁杰;蔡鸿福;刘茂柏;李娜
13 Cost-effectiveness of Osimertinib as First-line Treatment and Sequential Therapy for EGFR Mutation-positive Non-small Cell Lung Cancer in China 期刊论文 Cai Hongfu;Zhang Longfeng;Li Na;Chen Shen;Zheng Bin;Yang Jing;Weng Lizhu;Liu Mao Bai
14 First-Line Durvalumab Plus Platinum-Etoposide Versus Platinum-Etoposide for ExtensiveStage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis 期刊论文 Longfeng Zhang;Yongfu Hang;Maobai Liu;李娜;Hongfu Cai
15 Cost-Effectiveness Analysis Of Ceritinib And Alectinib Versus Crizotinib In The Treatment Of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer 期刊论文 Liu Maobai;Zhang Longfeng;Huang Qishu;Li Na;Zheng Bin;Cai Hongfu
16 Economic Evaluations of Immune Checkpoint Inhibitors for Patients with Non-Small Cell Lung Cancer: A Systematic Review. 期刊论文 Li Na;Zheng Huanrui;Zheng Bin;Chen Chaoxin;Cai Hongfu;Liu Maobai
17 Development and Testing of a Mobile App for Pain Management Among Cancer Patients Discharged From Hospital Treatment: Randomized Controlled Trial 期刊论文 Yang Jing;Weng Lizhu;Chen Zhikui;Cai Hongfu;Lin Xiaoyan;Hu Zhijian;Li Na;Lin Bijuan;Zheng Bin;Zhuang Qian;Du Bin;Zheng Zhiyuan;Liu Maobai
18 2021年福建医学科技奖-《药物经济学与循证药学在医院药学中的应用》 奖励 刘茂柏;郑斌;李娜;蔡鸿福;魏娜;黄敬泽;江玮
19 医保支付方式改革背景下的医院药学管理 专著 刘茂柏;王建华;李娜;郑斌;蔡鸿福;杨菁
查看更多信息请先登录或注册

相关项目

趋势报告

经验分享